109 related articles for article (PubMed ID: 17225686)
1. [Bladder cancer: understanding the disease and future implications for assessment and therapy].
Droller M
Rev Med Suisse; 2006 Dec; 2(90):2776-8, 2781-2, 2784. PubMed ID: 17225686
[TBL] [Abstract][Full Text] [Related]
2. [Non-invasive molecular detection of bladder cancer].
Hatachmi S
Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers for detection, surveillance and prognostication of bladder cancer.
Vrooman OP; Witjes JA
Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of bladder and kidney cancer.
Scélo G; Brennan P
Nat Clin Pract Urol; 2007 Apr; 4(4):205-17. PubMed ID: 17415353
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.
Dyrskjøt L; Zieger K; Real FX; Malats N; Carrato A; Hurst C; Kotwal S; Knowles M; Malmström PU; de la Torre M; Wester K; Allory Y; Vordos D; Caillault A; Radvanyi F; Hein AM; Jensen JL; Jensen KM; Marcussen N; Orntoft TF
Clin Cancer Res; 2007 Jun; 13(12):3545-51. PubMed ID: 17575217
[TBL] [Abstract][Full Text] [Related]
6. Bladder Cancer: current status of diagnosis & treatment.
Stanisic TH
Ariz Med; 1979 Jan; 36(1):34-7. PubMed ID: 420581
[No Abstract] [Full Text] [Related]
7. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
8. Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique.
Montironi R; Cheng L; Mazzucchelli R; Scarpelli M; Kirkali Z; Montorsi F; Lopez-Beltran A
Eur Urol; 2009 Jun; 55(6):1305-9. PubMed ID: 18995951
[No Abstract] [Full Text] [Related]
9. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
[TBL] [Abstract][Full Text] [Related]
10. Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis.
Ismaili N; Arifi S; Flechon A; El Mesbahi O; Blay JY; Droz JP; Errihani H
Bull Cancer; 2009 Jun; 96(6):E30-44. PubMed ID: 19457759
[TBL] [Abstract][Full Text] [Related]
11. Understanding bladder cancer death: tumor biology versus physician practice.
Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
[TBL] [Abstract][Full Text] [Related]
12. [Study of bladder cancer gene and relevant molecular biology should be strengthened].
Li CL; Han SJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):793-4. PubMed ID: 17565855
[No Abstract] [Full Text] [Related]
13. Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization.
Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Hirano M; Hayashida K; Mizumukai E; Nanaura H; Honda N
Oncol Rep; 2007 Nov; 18(5):1183-7. PubMed ID: 17914570
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers in bladder cancer.
Shariat SF; Karam JA; Lerner SP
Curr Opin Urol; 2008 Jan; 18(1):1-8. PubMed ID: 18090481
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
16. Stage of urinary bladder cancer at first presentation.
Al-Bazzaz PH
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):628-31. PubMed ID: 19587505
[TBL] [Abstract][Full Text] [Related]
17. Behavior of urothelial carcinoma with respect to anatomical location.
Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
19. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY
Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902
[TBL] [Abstract][Full Text] [Related]
20. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
